AlphaGenome 2: Google DeepMind's AI reads non-coding DNA to spot disease
Google DeepMind · · 30-second read
Top comments from YouTube.
This story is from November 11, 2026. For the latest, see today's news.
November 11, 2026 · AI Tech
Google DeepMind released AlphaGenome 2, an AI system that analyzes the 98% of human DNA responsible for controlling how cells function, rather than building proteins directly. The model uses transformer architecture to read non-coding DNA at single-cell resolution, identifying mutations that cause disease and explaining why most new drugs fail in clinical trials.
In a video interview, DeepMind researchers Žiga Avsec and Adam Gayoso discuss how AlphaGenome works, the AlphaGenome Atlas resource it created, and how the technology pinpoints disease-causing variants. The model represents a shift toward understanding the molecular blueprint of human life by decoding regulatory DNA sequences that were previously difficult to interpret computationally.
This is an AI-written summary. The original reporting belongs to Google DeepMind. How we write these · Spot a mistake?
Get the AI brief every morning.
The five AI stories that matter each morning: startups, money, jobs, tech and what's coming next. Free, and one click to unsubscribe. See our Privacy Policy.